- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Dynamic Healthcare launches clinical ASP for hospitals, docs
Dynamic Healthcare launches clinical ASP for hospitals, docsDynamic Healthcare Technologies has introduced CoMed, a suite of clinical connectivity and application services for physicians, hospitals, and ambulatory clinics. CoMed, for
Dynamic Healthcare launches clinical ASP for hospitals, docs
Dynamic Healthcare Technologies has introduced CoMed, a suite of clinical connectivity and application services for physicians, hospitals, and ambulatory clinics. CoMed, for collaborative medicine, is designed to enhance the capture and dissemination of clinical and diagnostic information in any form and enable anywhere/anytime access by physicians and other healthcare providers across the enterprise. Specific capabilities offered through CoMed include access to pathology and radiology reports and images, voice recognition for transcription and dictation of clinical interpretations, access to online medical references and news, and collaboration with colleagues during the diagnostic process. Dynamic plans to manage, host, and deliver CoMed as a subscription service.
- Search Again
- Return To HNN Homepage
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
